A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

NCT03276936 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
504
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vyne Therapeutics Inc.